Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Dev Med Child Neurol ; 64(3): 331-339, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34431088

RESUMEN

AIM: To study sex differences in attention-deficit/hyperactivity disorder (ADHD) symptoms, we explored whether X chromosome absence or excess is independently associated with deficits in attention and hyperactivity, executive function, and processing speed. METHOD: We assessed 116 children (ages 3y 10mo-11y 11mo, mean 8y 5mo, SD 1y 11mo) with a variable number of sex chromosomes: 36 females with Turner syndrome (45, X0), 20 males with Klinefelter syndrome (47, XXY), 37 typically developing females (XX), and 23 typically developing males (XY). RESULTS: X chromosome absence was associated with increased attention problems, hyperactivity, and deficits in inhibitory control, compared with female children with XX (all p<0.003). Conversely, X chromosome excess was associated with weakness in working memory (p=0.018) and approached significance for attention problems (p=0.071) but not with hyperactivity, or weakness in inhibitory control relative to male children with XY. Using non-parametric effect size to quantify the clinical effect revealed that X chromosome absence affected attention, hyperactivity, executive function, and processing speed (all r>0.4), while X excess affected in-laboratory as well as parent-reported working memory (all r>0.4). INTERPRETATION: Our observations provide compelling evidence that the absence or excess of an X chromosome distinctly affects cognition and behaviors associated with ADHD.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/genética , Trastorno por Déficit de Atención con Hiperactividad/fisiopatología , Cromosomas Humanos X/genética , Función Ejecutiva/fisiología , Inhibición Psicológica , Memoria a Corto Plazo/fisiología , Desempeño Psicomotor/fisiología , Caracteres Sexuales , Niño , Preescolar , Femenino , Humanos , Síndrome de Klinefelter/genética , Síndrome de Klinefelter/fisiopatología , Masculino , Síndrome de Turner/genética , Síndrome de Turner/fisiopatología
2.
Neuropsychopharmacology ; 44(1): 9-21, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30127341

RESUMEN

The study of sexual dimorphism in psychiatric and neurodevelopmental disorders is challenging due to the complex interplay of diverse biological, psychological, and social factors. Males are more susceptible to neurodevelopmental disorders including intellectual disability, autism spectrum disorder, and attention-deficit activity disorder. Conversely, after puberty, females are more prone to major depressive disorder and anxiety disorders compared to males. One major biological factor contributing to sex differences is the sex chromosomes. First, the X and Y chromosomes have unique and specific genetic effects as well as downstream gonadal effects. Second, males have one X chromosome and one Y chromosome, while females have two X chromosomes. Thus, sex chromosome constitution also differs between the sexes. Due to this complexity, determining genetic and downstream biological influences on sexual dimorphism in humans is challenging. Sex chromosome aneuploidies, such as Turner syndrome (X0) and Klinefelter syndrome (XXY), are common genetic conditions in humans. The study of individuals with sex chromosome aneuploidies provides a promising framework for studying sexual dimorphism in neurodevelopmental and psychiatric disorders. Here we will review and contrast four syndromes caused by variation in the number of sex chromosomes: Turner syndrome, Klinefelter syndrome, XYY syndrome, and XXX syndrome. Overall we describe an increased rate of attention-deficit hyperactivity disorder and autism spectrum disorder, along with the increased rates of major depressive disorder and anxiety disorders in one or more of these conditions. In addition to contributing unique insights about sexual dimorphism in neuropsychiatric disorders, awareness of the increased risk of neurodevelopmental and psychiatric disorders in sex chromosome aneuploidies can inform appropriate management of these common genetic disorders.


Asunto(s)
Síndrome de Klinefelter/genética , Trastornos Mentales/genética , Caracteres Sexuales , Trastornos de los Cromosomas Sexuales del Desarrollo Sexual/genética , Trastornos de los Cromosomas Sexuales/genética , Cromosomas Sexuales , Trisomía/genética , Síndrome de Turner/genética , Cariotipo XYY/genética , Cromosomas Humanos X/genética , Femenino , Humanos , Síndrome de Klinefelter/psicología , Masculino , Trastornos Mentales/psicología , Aberraciones Cromosómicas Sexuales , Trastornos de los Cromosomas Sexuales/psicología , Trastornos de los Cromosomas Sexuales del Desarrollo Sexual/psicología , Síndrome de Turner/psicología , Cariotipo XYY/psicología
3.
Ann Neurol ; 80(6): 811-820, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27761938

RESUMEN

The mechanisms underlying the high prevalence of cutaneous malignant melanoma (CMM) in Parkinson disease (PD) are unclear, but plausibly involve common pathways. 129Ser-phosphorylated α-synuclein, a pathological PD hallmark, is abundantly expressed in CMM, but not in normal skin. In inherited PD, PARK genes harbor germline mutations; the same genes are somatically mutated in CMM, or their encoded proteins are involved in melanomagenesis. Conversely, genes associated with CMM affect PD risk. PD/CMM-targeted cells share neural crest origin and melanogenesis capability. Pigmentation gene variants may underlie their susceptibility. We review putative genetic intersections that may be suggestive of shared pathways in neurodegeneration/melanomagenesis. Ann Neurol 2016;80:811-820.


Asunto(s)
Melanoma/complicaciones , Melanoma/genética , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/genética , Neoplasias Cutáneas/complicaciones , Neoplasias Cutáneas/genética , Inhibidor p16 de la Quinasa Dependiente de Ciclina , Inhibidor p18 de las Quinasas Dependientes de la Ciclina/genética , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Proteínas Asociadas a la Enfermedad de Parkinson/genética , Polimorfismo de Nucleótido Simple , Receptor de Melanocortina Tipo 1/genética , Receptores de N-Metil-D-Aspartato/genética , alfa-Sinucleína/genética , Melanoma Cutáneo Maligno
4.
Eur J Intern Med ; 22(3): 262-5, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21570645

RESUMEN

BACKGROUND: Guidelines recommend that LDL-C level should be <100mg/dl among diabetes mellitus (DM) and coronary heart disease (CHD) patients. OBJECTIVE: To evaluate how patients with DM and CHD differ in attaining the target level and to examine the association between goal achievement, demographic and clinical parameters. METHODS: The study was conducted in Maccabi Healthcare Services, the second largest health maintenance organization in Israel. All patients with DM (n=54,261), CHD (n=24,083) or DM and CHD (n=15,370) who were listed in the computerized database and had at least one LDL-C level measurement between January 1, 2007 and July 15, 2008 were eligible. The percentage of patients who attained LDL-C level <100mg/dl and its association with demographic and clinical parameters were analyzed. RESULTS: The rate of reaching the LDL-C target level was higher among the CHD and CHD and DM patients than DM ones (67% vs. 57% vs. 50%, p<0.001, respectively). Male gender; 5th socioeconomic status quintile; underlying disease i.e. CHD, CHD and DM; high statins compliance; and revascularization by percutaneous coronary intervention predicted for reaching target level. DM; absence of renal function evaluation; hospitalizations; HbA1C>7% or missing its measurements had a negative predictive value. CONCLUSIONS: The rate of reaching LDL-C target level should be increased in all high risk patients, mainly diabetic ones. Efforts should include educational programs to physicians and patients regarding the importance, the need to adhere and to intensify the cholesterol lowering treatment.


Asunto(s)
LDL-Colesterol/sangre , Enfermedad de la Arteria Coronaria/sangre , Diabetes Mellitus/sangre , Hipercolesterolemia/sangre , Anciano , Anciano de 80 o más Años , Enfermedad de la Arteria Coronaria/epidemiología , Bases de Datos Factuales/estadística & datos numéricos , Diabetes Mellitus/epidemiología , Femenino , Adhesión a Directriz/estadística & datos numéricos , Sistemas Prepagos de Salud/estadística & datos numéricos , Humanos , Hipercolesterolemia/epidemiología , Israel/epidemiología , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Valor Predictivo de las Pruebas , Factores de Riesgo
5.
Ann Epidemiol ; 20(2): 136-42, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20123164

RESUMEN

PURPOSE: In recent years, there is a growing body of evidence suggesting that statins may have anti-inflammatory effects; consequently, it was hypothesized that statins may have a preventive effect against cataract. METHODS: The study was carried out on a retrospective cohort of 180,291 new statin users in a large health organization in Israel. Study participants were followed between 1998 and 2007 for incident cataract or cataract extraction. RESULTS: During the study period 27,301 cataracts were diagnosed and 6,976 cataract extractions were performed among study participants. Persistence with statins was associated significantly (P < 0.001) with a reduced risk of cataract in men and women aged 45 to 74. Men aged 45-54 with a high (>80%) proportion of follow-up days covered with statins had an adjusted hazard ratio of 0.62 (95% confidence interval: 0.54-0.72), compared with patients with low persistence with statins. In elderly patients, no relationship or a positive relationship was observed. CONCLUSIONS: Persistent statin use was significantly protective for the incidence of cataract in men and women under 75 years of age.


Asunto(s)
Antiinflamatorios/administración & dosificación , Catarata/epidemiología , Inhibidores de Hidroximetilglutaril-CoA Reductasas/administración & dosificación , Adulto , Anciano , Catarata/prevención & control , Catarata/terapia , Extracción de Catarata , Estudios de Cohortes , Femenino , Sistemas Prepagos de Salud , Humanos , Israel/epidemiología , Masculino , Registros Médicos , Persona de Mediana Edad , Estudios Retrospectivos
6.
Cancer Causes Control ; 21(6): 879-87, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20148361

RESUMEN

Type 2 diabetes mellitus has been associated with an increased risk of a variety of cancers in observational studies, but few have reported the relationship between diabetes and cancer risk in men and women separately. The main goal of this retrospective cohort study was to evaluate the sex-specific risk of incident overall and site-specific cancer among people with DM compared with those without, who had no reported history of cancer at the start of the follow-up in January 2000. During an average of 8 years of follow-up (SD = 2.5), we documented 1,639 and 7,945 incident cases of cancer among 16,721 people with DM and 83,874 free of DM, respectively. In women, DM was associated with an adjusted hazard ratio of 1.96 (95% CI: 1.53-2.50) and 1.41 (95% CI: 1.20-1.66) for cancers of genital organs and digestive organs, respectively. A significantly reduced HR was observed for skin cancer (0.38; 95% CI: 0.22-0.66). In men with DM, there was no significant increase in overall risk of cancer. DM was related with a 47% reduction in the risk of prostate cancer. These findings suggest that the nature of the association between DM and cancer depends on sex and specific cancer site.


Asunto(s)
Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus/epidemiología , Neoplasias/etiología , Anciano , Estudios de Cohortes , Recolección de Datos , Femenino , Humanos , Israel , Masculino , Persona de Mediana Edad , Neoplasias del Sistema Nervioso/complicaciones , Pacientes , Grupos de Población , Estudios Retrospectivos , Factores de Riesgo
7.
Health Policy ; 95(2-3): 271-6, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20061044

RESUMEN

OBJECTIVES: The aim of this study was to assess the direct medical cost of treating major chronic illnesses in Maccabi Healthcare Services, a 1.8 million member health maintenance organization in Israel. METHODS: Direct medical costs were calculated for each member in 2006. We used multiple linear regression models to evaluate the overall costs of chronic conditions (cardiovascular diseases, diabetes mellitus, hypertension, female infertility treatments, and cancer), pregnancy and treatments for female infertility. RESULTS: According to the study model, hypertension was associated with the largest direct medical costs in both sexes. Cardiovascular diseases accounted for 9.5% of the total direct medical costs in men, but only 5.9% in women. Diabetes mellitus accounted for 3.5% of the total medical costs both in men and women and is comparable to the total pregnancy-related costs in women. CONCLUSIONS: The findings indicate that hypertension, diabetes mellitus and female infertility treatments impose a considerable economic burden on public healthcare services in Israel which is comparable with the costs of cancer and cardiovascular diseases.


Asunto(s)
Enfermedad Crónica/economía , Costo de Enfermedad , Costos Directos de Servicios/estadística & datos numéricos , Sistemas Prepagos de Salud/economía , Infertilidad Femenina/economía , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades Cardiovasculares/economía , Enfermedades Cardiovasculares/epidemiología , Enfermedad Crónica/epidemiología , Diabetes Mellitus/economía , Diabetes Mellitus/epidemiología , Femenino , Investigación sobre Servicios de Salud , Humanos , Hipertensión/economía , Hipertensión/epidemiología , Infertilidad Femenina/epidemiología , Israel/epidemiología , Modelos Lineales , Masculino , Servicios de Salud Materna/economía , Persona de Mediana Edad , Análisis Multivariante , Programas Nacionales de Salud/economía , Neoplasias/economía , Neoplasias/epidemiología , Embarazo , Prevalencia
8.
Hum Biol ; 81(4): 463-77, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20067370

RESUMEN

Birth weight is the single most significant determinant of infant mortality and the chances of a newborn to experience healthy development. Low birth weight also appears to be related to higher risks of several important chronic conditions, such as ischemic heart disease, non-insulin-dependent diabetes, and cancer in adults. Thus factors that influence in utero growth and birth weight may have a serious effect on health outcomes many years later in life. Analysis of seasonal variations in birth weights may enable us to suggest specific factors that influence this measure. In this review we summarize the literature on seasonal variations in birth weight. Although causes of seasonal variation in developing regions are more clearly understood, it is not yet clear which factors affect apparent seasonal variation in birth weight in developed countries. In our analysis we observed a pattern of seasonal variations in developed countries that differed between low-, middle-, and high-latitude countries, and we suggest several mechanisms that may be responsible for this diversity. Namely, we suggest that in middle-latitude climates, the large annual temperature range may cause low birth weights during summer, whereas in high- and low-latitude regions variations in sunlight exposure between seasons may contribute to low birth weights apparent during winter. Identification of the suggested causal environmental factors may have public health implications in the development of primary prevention programs for low birth weight and macrosomia in developed countries.


Asunto(s)
Peso al Nacer , Estaciones del Año , Salud Global , Humanos , Recién Nacido , Nacimiento Prematuro , Factores de Riesgo
9.
Exp Neurol ; 215(1): 101-9, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18951894

RESUMEN

In recent years there have been several attempts to establish high frequency stimulation (HFS) as an additional treatment strategy for obsessive-compulsive disorder (OCD). Two studies reported that bilateral HFS of the subthalamic nucleus (STN) dramatically alleviated compulsions and improved obsessions in three patients with co-morbid Parkinson's disease and OCD. A recent study reported that HFS as well as pharmacological inactivation of the STN alleviate compulsive checking in the quinpirole rat model of OCD. As the quinpirole model is based on a dopaminergic manipulation, the aim of the present study was to test whether HFS and pharmacological inactivation of the STN exert an anti-compulsive effect also in the drug-naive brain, using the signal attenuation rat model of OCD. The main finding of the present study is that both HFS and pharmacological inactivation of the STN exerted an anti-compulsive effect, although the two manipulations differed in their effects on other behavioral measures. These findings support the possibility that HFS of the STN may provide an additional therapeutic strategy for OCD.


Asunto(s)
Conducta Compulsiva/fisiopatología , Conducta Compulsiva/terapia , Condicionamiento Operante/fisiología , Estimulación Encefálica Profunda/métodos , Núcleo Subtalámico/fisiología , Análisis de Varianza , Animales , Conducta Animal , Condicionamiento Operante/efectos de los fármacos , Modelos Animales de Enfermedad , Extinción Psicológica/efectos de los fármacos , Extinción Psicológica/fisiología , Agonistas del GABA/farmacología , Masculino , Microinyecciones/métodos , Muscimol/farmacología , Desempeño Psicomotor/efectos de los fármacos , Desempeño Psicomotor/fisiología , Ratas , Ratas Sprague-Dawley , Núcleo Subtalámico/efectos de los fármacos , Factores de Tiempo
10.
Eur J Neurosci ; 27(8): 1902-11, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18412611

RESUMEN

Different lines of evidence point to dysfunction of basal ganglia-thalamocortical circuits in obsessive-compulsive disorder (OCD). It has been hypothesized that the circuits' dysfunction in OCD may be characterized by a relative under-activity of the indirect compared with the direct pathway within these circuits. The present study tested whether lesions of the subthalamic nucleus (STN), a major node of the indirect pathway, would affect compulsive behavior, using the signal attenuation rat model of OCD. In this model, compulsive lever-pressing is induced by the attenuation of an external signal of reward delivery; an attenuation that is hypothesized to simulate the deficient response feedback suggested to underlie obsessions and compulsions in patients with OCD. Rats sustaining lesions to the STN showed a selective increase in compulsive lever-pressing compared with sham-operated rats. A post mortem biochemical analysis revealed a decrease in serotonin content in the prelimbic and infralimbic cortices, caudate-putamen (but not nucleus accumbens), globus pallidus and substantia nigra-ventral tegmental area, as well as a decrease in dopamine content in the caudate-putamen in STN-lesioned compared with sham rats. A comparison to recent findings that lesions to the orbitofrontal cortex, which also result in a selective increase in compulsive lever-pressing, lead to a decrease in serotonin and dopamine content in the caudate-putamen suggests that there may be a final common pathway by which different brain pathologies may lead to a pro-compulsive state.


Asunto(s)
Conducta Compulsiva/metabolismo , Dopamina/metabolismo , Serotonina/metabolismo , Núcleo Subtalámico/metabolismo , Animales , Conducta Animal , Conducta Compulsiva/fisiopatología , Trastorno Obsesivo Compulsivo/metabolismo , Trastorno Obsesivo Compulsivo/fisiopatología , Ratas , Ratas Sprague-Dawley , Recompensa , Núcleo Subtalámico/lesiones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...